Cargando…

New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?

Detalles Bibliográficos
Autores principales: Zhou, Taotao, Fronhoffs, Florian, Dold, Leona, Strassburg, Christian P., Weismüller, Tobias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384483/
https://www.ncbi.nlm.nih.gov/pubmed/34450237
http://dx.doi.org/10.1016/j.jhep.2021.08.006
_version_ 1783741923048030208
author Zhou, Taotao
Fronhoffs, Florian
Dold, Leona
Strassburg, Christian P.
Weismüller, Tobias J.
author_facet Zhou, Taotao
Fronhoffs, Florian
Dold, Leona
Strassburg, Christian P.
Weismüller, Tobias J.
author_sort Zhou, Taotao
collection PubMed
description
format Online
Article
Text
id pubmed-8384483
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-83844832021-08-25 New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant? Zhou, Taotao Fronhoffs, Florian Dold, Leona Strassburg, Christian P. Weismüller, Tobias J. J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2022-01 2021-08-25 /pmc/articles/PMC8384483/ /pubmed/34450237 http://dx.doi.org/10.1016/j.jhep.2021.08.006 Text en © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Zhou, Taotao
Fronhoffs, Florian
Dold, Leona
Strassburg, Christian P.
Weismüller, Tobias J.
New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title_full New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title_fullStr New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title_full_unstemmed New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title_short New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
title_sort new-onset autoimmune hepatitis following mrna covid-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis – should we be more vigilant?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384483/
https://www.ncbi.nlm.nih.gov/pubmed/34450237
http://dx.doi.org/10.1016/j.jhep.2021.08.006
work_keys_str_mv AT zhoutaotao newonsetautoimmunehepatitisfollowingmrnacovid19vaccinationina36yearoldwomanwithprimarysclerosingcholangitisshouldwebemorevigilant
AT fronhoffsflorian newonsetautoimmunehepatitisfollowingmrnacovid19vaccinationina36yearoldwomanwithprimarysclerosingcholangitisshouldwebemorevigilant
AT doldleona newonsetautoimmunehepatitisfollowingmrnacovid19vaccinationina36yearoldwomanwithprimarysclerosingcholangitisshouldwebemorevigilant
AT strassburgchristianp newonsetautoimmunehepatitisfollowingmrnacovid19vaccinationina36yearoldwomanwithprimarysclerosingcholangitisshouldwebemorevigilant
AT weismullertobiasj newonsetautoimmunehepatitisfollowingmrnacovid19vaccinationina36yearoldwomanwithprimarysclerosingcholangitisshouldwebemorevigilant